Metabolic alterations in a rat model of takotsubo syndrome.
Animals
Calcium
/ metabolism
Fatty Acids
/ metabolism
Female
Flavin-Adenine Dinucleotide
/ metabolism
Fluorodeoxyglucose F18
Glucose
/ metabolism
Inflammation
/ metabolism
Malonyl Coenzyme A
/ metabolism
Myocardium
/ metabolism
NAD
/ metabolism
Oxidation-Reduction
RNA
/ metabolism
Rats
Takotsubo Cardiomyopathy
/ metabolism
Energetics
Heart failure
Inflammation
Metabolism
Remodelling
Takotsubo
Journal
Cardiovascular research
ISSN: 1755-3245
Titre abrégé: Cardiovasc Res
Pays: England
ID NLM: 0077427
Informations de publication
Date de publication:
29 06 2022
29 06 2022
Historique:
received:
17
07
2020
accepted:
09
03
2021
pubmed:
13
3
2021
medline:
1
7
2022
entrez:
12
3
2021
Statut:
ppublish
Résumé
Cardiac energetic impairment is a major finding in takotsubo patients. We investigate specific metabolic adaptations to direct future therapies. An isoprenaline-injection female rat model (vs. sham) was studied at Day 3; recovery assessed at Day 7. Substrate uptake, metabolism, inflammation, and remodelling were investigated by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography, metabolomics, quantitative PCR, and western blot (WB). Isolated cardiomyocytes were patch-clamped during stress protocols for redox states of NAD(P)H/FAD or [Ca2+]c, [Ca2+]m, and sarcomere length. Mitochondrial respiration was assessed by seahorse/Clark electrode (glycolytic and β-oxidation substrates). Cardiac 18F-FDG metabolic rate was increased in takotsubo (P = 0.006), as was the expression of GLUT4-RNA/GLUT1/HK2-RNA and HK activity (all P < 0.05), with concomitant accumulation of glucose- and fructose-6-phosphates (P > 0.0001). Both lactate and pyruvate were lower (P < 0.05) despite increases in LDH-RNA and PDH (P < 0.05 both). β-Oxidation enzymes CPT1b-RNA and 3-ketoacyl-CoA thiolase were increased (P < 0.01) but malonyl-CoA (CPT-1 regulator) was upregulated (P = 0.01) with decreased fatty acids and acyl-carnitines levels (P = 0.0001-0.02). Krebs cycle intermediates α-ketoglutarate and succinyl-carnitine were reduced (P < 0.05) as was cellular ATP reporter dihydroorotate (P = 0.003). Mitochondrial Ca2+ uptake during high workload was impaired on Day 3 (P < 0.0001), inducing the oxidation of NAD(P)H and FAD (P = 0.03) but resolved by Day 7. There were no differences in mitochondrial respiratory function, sarcomere shortening, or [Ca2+] transients of isolated cardiomyocytes, implying preserved integrity of both mitochondria and cardiomyocyte. Inflammation and remodelling were upregulated-increased CD68-RNA, collagen RNA/protein, and skeletal actin RNA (all P < 0.05). Dysregulation of glucose and lipid metabolic pathways with decreases in final glycolytic and β-oxidation metabolites and reduced availability of Krebs intermediates characterizes takotsubo myocardium. The energetic deficit accompanies defective Ca2+ handling, inflammation, and upregulation of remodelling pathways, with the preservation of sarcomeric and mitochondrial integrity.
Identifiants
pubmed: 33711093
pii: 6169160
doi: 10.1093/cvr/cvab081
pmc: PMC9239582
doi:
Substances chimiques
Fatty Acids
0
NAD
0U46U6E8UK
Fluorodeoxyglucose F18
0Z5B2CJX4D
Flavin-Adenine Dinucleotide
146-14-5
Malonyl Coenzyme A
524-14-1
RNA
63231-63-0
Glucose
IY9XDZ35W2
Calcium
SY7Q814VUP
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1932-1946Subventions
Organisme : British Heart Foundation
ID : FS/16/39/32174
Pays : United Kingdom
Organisme : British Heart Foundation
ID : NH/19/1/34595
Pays : United Kingdom
Organisme : British Heart Foundation
ID : PG/18/35/33786
Pays : United Kingdom
Organisme : British Heart Foundation
ID : FS/RTF/20/30009
Pays : United Kingdom
Organisme : British Heart Foundation
ID : CS/17/4/32960
Pays : United Kingdom
Organisme : British Heart Foundation
ID : PG/15/88/31780
Pays : United Kingdom
Organisme : British Heart Foundation
ID : PG/17/64/33205
Pays : United Kingdom
Commentaires et corrections
Type : CommentIn
Informations de copyright
© The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology.
Références
Atherosclerosis. 2005 Jan;178(1):67-73
pubmed: 15585202
J Am Coll Cardiol. 2012 Jan 10;59(2):153-63
pubmed: 22222080
Cell Rep. 2015 Jul 7;12(1):15-22
pubmed: 26119742
Exp Physiol. 2006 May;91(3):571-80
pubmed: 16452123
Methods Mol Biol. 2007;357:271-96
pubmed: 17172694
J Am Coll Cardiol. 2003 Mar 5;41(5):743-8
pubmed: 12628716
Eur Heart J. 2013 Feb;34(5):397
pubmed: 22922294
J Mol Cell Cardiol. 1997 Jun;29(6):1675-85
pubmed: 9220353
Circulation. 2010 Nov 30;122(22):2273-80
pubmed: 21098439
J Am Coll Cardiol. 2017 Aug 22;70(8):975-991
pubmed: 28818208
J Vis Exp. 2015 Oct 30;(105):e53216
pubmed: 26555567
Int J Cardiol. 2010 Oct 8;144(2):212-8
pubmed: 19443060
Cell Rep. 2015 Jul 7;12(1):23-34
pubmed: 26119731
Circulation. 2019 Mar 26;139(13):1581-1592
pubmed: 30586731
PLoS One. 2017 Oct 19;12(10):e0186656
pubmed: 29049352
Biochem J. 1993 Oct 1;295 ( Pt 1):287-93
pubmed: 8216230
Eur J Heart Fail. 2013 Jan;15(1):9-22
pubmed: 23099354
Circulation. 2018 Mar 6;137(10):1039-1048
pubmed: 29128863
Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2525-9
pubmed: 1706526
PLoS One. 2012;7(7):e40221
pubmed: 22844400
Circ Res. 1997 Jan;80(1):82-7
pubmed: 8978326
Biophys J. 2003 Apr;84(4):2734-55
pubmed: 12668482
Cardiovasc Res. 1999 Apr;42(1):246-53
pubmed: 10435017
J Nucl Med. 2006 Nov;47(11):1891-900
pubmed: 17079824
Int J Cardiol. 2015;189:112-4
pubmed: 25889440
Anal Chem. 2009 Aug 15;81(16):6656-67
pubmed: 19624122
J Pathol. 2003 Mar;199(3):387-97
pubmed: 12579541
Int J Cardiol. 2013 Oct 3;168(3):1943-50
pubmed: 23357048
Cell Metab. 2015 Sep 1;22(3):472-84
pubmed: 26256392
J Mol Cell Cardiol. 2011 Jan;50(1):230-8
pubmed: 20971119
Eur Heart J. 2007 Nov;28(21):2598-604
pubmed: 17921529
Circ Res. 2018 May 11;122(10):1460-1478
pubmed: 29748369
JACC Basic Transl Sci. 2018 Apr 18;3(2):213-226
pubmed: 30062207
N Engl J Med. 2015 Sep 3;373(10):929-38
pubmed: 26332547
Br J Pharmacol. 2014 Apr;171(8):2080-90
pubmed: 24147975
J Am Soc Echocardiogr. 2017 Aug;30(8):745-755
pubmed: 28599831
JACC Basic Transl Sci. 2018 Dec 31;3(6):766-778
pubmed: 30623136
J Biol Chem. 1989 Aug 15;264(23):13430-9
pubmed: 2503501
Circ Res. 2012 Sep 14;111(7):863-75
pubmed: 22777004
Circulation. 2012 Nov 20;126(21):e324-6
pubmed: 23169256
Cell Metab. 2011 Apr 6;13(4):461-468
pubmed: 21459330
Circ Res. 2006 Jul 21;99(2):172-82
pubmed: 16778127